Mirum Pharmaceuticals, Inc.
MIRM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001759425
In the last 90 days, Mirum Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 10 sales; 326 institutions reported holding it in 13F filings for Q2 2026, worth $8.36B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Mirum Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 10 filings
- 3 insiders, $14.2M in total
- Insiders trading
- 3
- Net value
- −$14.2M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Mirum Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Bjerkholt Eric | CHIEF FINANCIAL OFFICER | 44,745 | Sep 15, 2026 | 8 |
| Howe Jolanda | SVP, GLOBAL CONTROLLER | 616 | Sep 3, 2026 | 10 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | 194,440 | Sep 3, 2026 | 11 |
| Grey Michael G | Director | 0 | Jun 17, 2026 | 4 |
| Walbert Timothy P | Director | 9,680 | Jun 17, 2026 | 2 |
| Heron Patrick J | Director | 459,010Indirect | Jun 17, 2026 | 2 |
| Brege Laura | Director | 15,703 | Jun 17, 2026 | 1 |
| Fischer Laurent | Director | 10,727 | Jun 17, 2026 | 2 |
| Ramasastry Saira | Director | 0 | Jun 17, 2026 | 9 |
| Fairey William | Director | 2,500 | Jun 17, 2026 | 1 |
| Cardon Lon | Director | 9,680 | Jun 17, 2026 | 2 |
| Radovich Peter | PRESIDENT AND COO | 57,260 | Jun 8, 2026 | 7 |
| Quan Joanne | CHIEF MEDICAL OFFICER | 18,864 | Mar 17, 2026 | 4 |
| Vig Pamela | CHIEF SCIENTIFIC OFFICER | 27,406 | Jun 25, 2024 | 0 |
| Longpre Lara | CHIEF DEVELOPMENT OFFICER | 104,369 | Mar 18, 2024 | 0 |
| NEA Partners 16, L.P. | 10% Owner | 0 | Jun 15, 2023 | 0 |
| Nea 16 GP, LLC | 10% Owner | 0 | Jun 15, 2023 | 0 |
| Sandell Scott D | 10% Owner | 11,348Indirect | Jun 15, 2023 | 0 |
| Baskett Forest | 10% Owner | 1,548Indirect | Jun 15, 2023 | 0 |
| Walker Paul Edward | 10% Owner | 114Indirect | Jun 15, 2023 | 0 |
| Florence Anthony A. Jr. | 10% Owner | 11,348Indirect | Jun 15, 2023 | 0 |
| Behbahani Ali | 10% Owner | 135Indirect | Jun 15, 2023 | 0 |
| Makhzoumi Mohamad | 10% Owner | 11,348Indirect | Jun 15, 2023 | 0 |
| New Enterprise Associates 16, L.P. | 10% Owner | 2,186,243 | Jun 15, 2023 | 0 |
| Chang Carmen | 10% Owner | 135 | Jun 15, 2023 | 0 |
| O'Donnell Niall | Director | 1,621,118Indirect | Nov 15, 2022 | 0 |
| Clements Ian | Chief Financial Officer | 30,011 | Nov 14, 2022 | 0 |
| Deerfield Management Company, L.P. | 10% Owner, Other: * Possible Member of 10% Group | 1,540,190Indirect | Jun 8, 2022 | 0 |
| Flynn James E | 10% Owner, Other: * Possible Member of 10% Group | 1,540,190Indirect | Jun 8, 2022 | 0 |
| Deerfield Healthcare Innovations Fund, L.P. | 10% Owner, Other: * Possible Member of 10% Group | 1,540,190Indirect | Jun 8, 2022 | 0 |
| Deerfield Mgmt HIF, L.P. | 10% Owner, Other: * Possible Member of 10% Group | 1,540,190Indirect | Jun 8, 2022 | 0 |
| Deerfield Private Design Fund IV, L.P. | 10% Owner, Other: * Possible Member of 10% Group | 1,540,190Indirect | Jun 8, 2022 | 0 |
| Deerfield Mgmt IV, L.P. | 10% Owner, Other: * Possible Member of 10% Group | 1,540,190Indirect | Jun 8, 2022 | 0 |
| Mathers Edward T | Director | – | Jun 6, 2022 | 0 |
| Brosgart Carol L | Director | – | Jun 6, 2022 | 0 |
| Tucker Edwin Jonathan | Chief Medical Officer | 45,838 | Nov 15, 2021 | 0 |
| Deerfield Mgmt L.P. | 10% Owner, Other: * Possible Member of 10% Group | 0Indirect | Jul 13, 2021 | 0 |
| Deerfield Special Situations Fund, L.P. | 10% Owner, Other: * Possible Member of 10% Group | 0Indirect | Jul 13, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2021 (view filing)6:48 PM ET | Jul 2-7 | 5 days | Deerfield Management Company, L.P. and 7 others10% Owner, Other: * Possible Member of 10% Group | SSale | −66.7K | $16.29 | −$1.09M | −40.2%99.3K after | 3 lots |
| Jul 13, 2021 (view filing)12:06 PM ET | Jul 9 | 4 days | Deerfield Management Company, L.P. and 7 others10% Owner, Other: * Possible Member of 10% Group | SSale | −99.3K | $15.81 | −$1.57M | −100.0%0 after | |
| Oct 1, 2021 (view filing) | Oct 1 | Same day | Tucker Edwin JonathanChief Medical Officer | SSale | −1.36K | $19.26 | −$26.3K | −2.9%45.8K after | |
| Oct 1, 2021 (view filing) | Oct 1 | Same day | Radovich PeterChief Operating Officer | SSale | −1.36K | $19.26 | −$26.3K | −10.8%11.3K after | |
| Oct 1, 2021 (view filing) | Oct 1 | Same day | Longpre LaraChief Development Officer | SSale | −961 | $19.26 | −$18.5K | −1.1%84.2K after | |
| Oct 1, 2021 (view filing) | Oct 1 | Same day | Clements IanChief Financial Officer | SSale | −1.57K | $19.26 | −$30.3K | −8.6%16.7K after | |
| Oct 1, 2021 (view filing) | Oct 1 | Same day | Vig PamelaChief Scientific Officer | SSale | −1.36K | $19.26 | −$26.3K | −12.4%9.67K after | |
| Oct 1, 2021 (view filing) | Oct 1 | Same day | Peetz ChristopherPresident and CEO | SSale | −3.67K | $19.26 | −$70.7K | −14.9%21.0K after | |
| Nov 29, 2021 (view filing) | Nov 24 | 5 days | Peetz ChristopherPresident and CEO | PPurchase | +7.00K | $14.40 | +$100.8K | +33.3%28.0K after | |
| Nov 29, 2021 (view filing) | Nov 24-26 | 5 days | Clements IanChief Financial Officer | PPurchase | +1.45K | $14.14 | +$20.5K | +8.5%18.6K after | 2 lots |
| Jun 8, 2022 (view filing)7:25 PM ET | Jun 6 | 2 days | Deerfield Management Company, L.P. and 5 others10% Owner, Other: * Possible Member of 10% Group | SSale | −38.5K | $25.01 | −$962.3K | −2.4%1.54M after | 6 lots |
| Nov 15, 2022 (view filing) | Nov 11-15 | 4 days | O'Donnell NiallDirector | SSale | −300.0K | $19.85 | −$5.96M | −15.6%1.62M after | 3 lots |
| May 4, 2023 (view filing) | May 3 | 1 day | Grey Michael GDirector | SSale | −14.6K | $28.00 | −$409.0K | −100.0%0 after | 10b5-1 |
| Jun 9, 2023 (view filing) | Jun 8 | 1 day | Grey Michael GDirector | SSale | −14.6K | $29.00 | −$423.6K | −100.0%0 after | 10b5-1 |
| Jul 5, 2023 (view filing) | Jul 3 | 2 days | Peetz ChristopherPresident and CEO | SSale | −5.50K | $25.65 | −$141.0K | −4.6%115.3K after | |
| Jul 5, 2023 (view filing) | Jul 3 | 2 days | Howe JolandaSVP, Global Controller | SSale | −915 | $25.65 | −$23.5K | −20.9%3.46K after | |
| Jul 5, 2023 (view filing) | Jul 3 | 2 days | Vig PamelaHead of Research & Development | SSale | −1.43K | $25.65 | −$36.6K | −4.4%30.8K after | |
| Jul 5, 2023 (view filing) | Jul 3 | 2 days | Longpre LaraChief Development Officer | SSale | −1.00K | $25.65 | −$25.8K | −0.9%105.8K after | |
| Jul 5, 2023 (view filing) | Jul 3 | 2 days | Radovich PeterChief Operating Officer | SSale | −1.43K | $25.65 | −$36.6K | −3.6%37.7K after | |
| Aug 28, 2023 (view filing) | Aug 25 | 3 days | Howe JolandaSVP, Global Controller | SSale | −3.46K | $26.23 | −$90.7K | −100.0%0 after | |
| Sep 5, 2023 (view filing) | Aug 31 | 5 days | Heron Patrick JDirector, 10% Owner | PPurchase | +148.0K | $26.25 | +$3.88M | New position148.0K after | |
| Sep 12, 2023 (view filing) | Sep 11 | 1 day | Bjerkholt EricChief Financial Officer | PPurchase | +10.0K | $29.65 | +$296.5K | New position10.0K after | |
| Sep 13, 2023 (view filing) | Sep 11-12 | 2 days | Heron Patrick JDirector | PPurchase | +8.44K | $30.43 | +$256.8K | +5.7%156.4K after | 2 lots |
| Sep 14, 2023 (view filing) | Sep 13-14 | 1 day | Grey Michael GDirector | SSale | −14.6K | $32.00 | −$467.5K | −100.0%0 after | 2 lots |
| Sep 15, 2023 (view filing) | Sep 13 | 2 days | Heron Patrick JDirector | PPurchase | +2.63K | $31.02 | +$81.4K | +1.7%159.1K after | |
| Nov 14, 2023 (view filing) | Nov 9 | 5 days | Heron Patrick JDirector | PPurchase | +2.91K | $28.30 | +$82.4K | +1.8%162.0K after | |
| Dec 6, 2023 (view filing) | Dec 5 | 1 day | Howe JolandaSVP, Global Controller | SSale | −2.50K | $32.40 | −$81.0K | −100.0%0 after | |
| Jan 9, 2024 (view filing) | Jan 8 | 1 day | Howe JolandaSVP, GLOBAL CONTROLLER | SSale | −528 | $28.04 | −$14.8K | −42.2%722 after | |
| Jan 9, 2024 (view filing) | Jan 8 | 1 day | Peetz ChristopherPRESIDENT AND CEO | SSale | −5.21K | $28.03 | −$146.0K | −4.5%110.1K after | |
| Jan 9, 2024 (view filing) | Jan 8 | 1 day | Vig PamelaHEAD OF RESEARCH & DEVELOPMENT | SSale | −1.41K | $28.03 | −$39.5K | −4.5%29.9K after | |
| Jan 9, 2024 (view filing) | Jan 8 | 1 day | Longpre LaraCHIEF DEVELOPMENT OFFICER | SSale | −1.02K | $28.04 | −$28.6K | −1.0%105.3K after | |
| Jan 9, 2024 (view filing) | Jan 8 | 1 day | Radovich PeterCHIEF OPERATING OFFICER | SSale | −1.41K | $28.03 | −$39.5K | −3.7%36.5K after | |
| Feb 2, 2024 (view filing) | Feb 2 | Same day | Howe JolandaSVP, GLOBAL CONTROLLER | SSale | −735 | $26.19 | −$19.2K | −29.5%1.76K after | |
| Feb 5, 2024 (view filing) | Feb 2 | 3 days | Peetz ChristopherCHIEF EXECUTIVE OFFICER | SSale | −6.01K | $26.19 | −$157.5K | −5.5%104.1K after | |
| Feb 5, 2024 (view filing) | Feb 2 | 3 days | Radovich PeterPRESIDENT AND COO | SSale | −1.79K | $26.19 | −$46.9K | −4.9%34.7K after | |
| Feb 5, 2024 (view filing) | Feb 2 | 3 days | Longpre LaraCHIEF DEVELOPMENT OFFICER | SSale | −847 | $26.19 | −$22.2K | −0.8%104.4K after | |
| Feb 5, 2024 (view filing) | Feb 2 | 3 days | Vig PamelaCHIEF SCIENTIFIC OFFICER | SSale | −1.21K | $26.19 | −$31.8K | −4.1%28.7K after | |
| Mar 18, 2024 (view filing) | Mar 18 | Same day | Bjerkholt EricCHIEF FINANCIAL OFFICER | PPurchase | +2.00K | $25.80 | +$51.6K | +20.0%12.0K after | |
| Mar 18, 2024 (view filing) | Jan 9, 2023 | 434 daysLate | Peetz ChristopherCHIEF EXECUTIVE OFFICER | SSale | −5.16K | $20.62 | −$106.4K | −5.3%92.0K after | |
| Mar 18, 2024 (view filing) | Sep 10, 2019 | 1,651 daysLate | Longpre LaraCHIEF DEVELOPMENT OFFICER | PPurchase | +965 | $10.64 | +$10.3K | +0.9%105.4K after | |
| Mar 18, 2024 (view filing) | Jan 9, 2023 | 434 daysLate | Longpre LaraCHIEF DEVELOPMENT OFFICER | SSale | −1.00K | $20.62 | −$20.7K | −1.0%104.4K after | |
| Mar 18, 2024 (view filing) | Jan 9, 2023 | 434 daysLate | Vig PamelaCHIEF SCIENTIFIC OFFICER | SSale | −1.38K | $20.62 | −$28.4K | −4.8%27.3K after | |
| Mar 18, 2024 (view filing) | Jan 9, 2023 | 434 daysLate | Radovich PeterPRESIDENT AND COO | SSale | −1.38K | $20.62 | −$28.4K | −4.0%33.3K after | |
| Mar 25, 2024 (view filing) | Mar 25 | Same day | Radovich PeterPRESIDENT AND COO | SSale | −4.30K | $25.80 | −$111.0K | −12.9%29.0K after | |
| Mar 27, 2024 (view filing) | Mar 27 | Same day | Bjerkholt EricCHIEF FINANCIAL OFFICER | PPurchase | +2.00K | $24.80 | +$49.6K | +16.7%14.0K after | |
| Jun 7, 2024 (view filing) | Jun 5 | 2 days | Ramasastry SairaDirector | SSale | −5.00K | $25.68 | −$128.4K | −100.0%0 after | 10b5-1 |
| Jun 25, 2024 (view filing) | Jun 24 | 1 day | Vig PamelaCHIEF SCIENTIFIC OFFICER | SSale | −30.6K | $34.00 | −$1.04M | −52.7%27.4K after | 10b5-1 |
| Jul 3, 2024 (view filing) | Jul 2 | 1 day | Howe JolandaSVP, GLOBAL CONTROLLER | SSale | −375 | $34.00 | −$12.8K | −13.4%2.43K after | |
| Sep 10, 2024 (view filing) | Sep 6 | 4 days | Heron Patrick JDirector | PPurchase | +230 | $41.58 | +$9.56K | +0.1%162.2K after | |
| Sep 20, 2024 (view filing) | Sep 18 | 2 days | Heron Patrick JDirector | PPurchase | +115 | $37.40 | +$4.30K | +0.1%162.3K after |